Alanine/EPR dosimetry for mailed intercomparison at ocular proton therapy facilities-preliminary results for three centres for irradaitions at CCB IFJ PAN eyeline
- PMID: 37721070
- PMCID: PMC10505937
- DOI: 10.1093/rpd/ncad127
Alanine/EPR dosimetry for mailed intercomparison at ocular proton therapy facilities-preliminary results for three centres for irradaitions at CCB IFJ PAN eyeline
Abstract
Quality control of therapeutic photon beams in the form of postal dose audits based on passive dosemeters is widely used in photon radiotherapy. On the other hand, no standardised dosimetry audit programme for proton centres has been established in Europe so far. We evaluated alanine/EPR dosimetry systems developed at the Istituto Superiore di Sanità (Italy), the Hasselt Universiteit (Belgium) and the Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences (Poland) for their applicability as a potential tool for routine mailed dose audits of passively scattered therapeutic proton beams. The evaluation was carried out in the form of an intercomparison. Dosemeters were irradiated in the 70 MeV proton beam at ocular proton therapy facility in the Cyclotron Centre Bronowice at the Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences in Krakow. A very good agreement was found between the dose measured by three laboratories and the delivered dose determined with an ionisation chamber. This, together with the inherent properties of alanine, such as non-destructive readout, tissue equivalence, weak energy dependence, dose rate independence and insignificant fading, makes alanine a good candidate for a dosemeter used in postal auditing in proton ocular radiotherapy.
© The Author(s) 2023. Published by Oxford University Press.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- International Atomic Energy Agency . Comprehensive Audits of Radiotherapy Practices: A Tool for Quality Improvement (Vienna: IAEA, Non-serial Publications; ) (2007).
-
- Ferreira, I. H., Dutreix, A., Bridier, A., Chavaudra, J. and Svensson, H. The ESTRO-QUALity assurance network (EQUAL). Radiother. Oncol. 55(3), 273–284 (2000). - PubMed
-
- Rozporządzenie Ministra Zdrowia z dnia 18 lutego 2011 r. w sprawie warunków bezpiecznego stosowania promieniowania jonizującego dla wszystkich rodzajów ekspozycji medycznej (t.j. Dz. U. z 2017 r. poz. 884).
-
- Carlino, A., Gouldstone, C., Kragl, G., Traneus, E., Marrale, M., Vatnitsky, S., Stock, M. and Palmans, H. End-to-end tests using alanine dosimetry in scanned proton beams. Phys. Med. Biol. 63(5), 055001 (2018). - PubMed
